IRLAB Therapeutics AB (publ) (STO: IRLAB.A)

IRLAB Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	747	611	703	641	464	555
Market Cap Growth	30.23%	-13.14%	9.64%	38.20%	-16.33%	57.30%
Enterprise Value	704	995	942	773	519	727
Last Close Price	14.40	21.72	24.43	21.59	15.85	18.37
PE Ratio	-	9.70	9.51	10.28	-721.80	11.00
PS Ratio	17.96	0.51	0.60	0.74	0.79	0.70
PB Ratio	10.72	0.95	1.16	1.19	0.99	1.15
P/FCF Ratio	11.66	4.43	-7.73	-71.25	17.18	28.88
P/OCF Ratio	11.01	3.99	-13.26	6.34	3.93	5.47
EV/Sales Ratio	16.93	0.84	0.81	0.90	0.88	0.91
EV/EBITDA Ratio	7.18	4.67	5.26	7.51	13.17	5.71
EV/EBIT Ratio	14.09	8.36	9.33	10.72	63.29	11.16
EV/FCF Ratio	16.78	7.21	-10.35	-85.92	19.22	37.84
Debt / Equity Ratio	0.67	0.65	0.70	0.22	0.10	0.35
Debt / EBITDA Ratio	2.42	1.96	2.36	0.90	0.76	1.31
Debt / FCF Ratio	6.44	3.02	-4.65	-12.96	1.82	8.69
Asset Turnover	0.69	0.86	0.96	1.04	0.80	0.95
Inventory Turnover	-	2.08	2.34	2.68	2.30	2.44
Quick Ratio	2.54	0.91	0.56	0.63	1.10	1.36
Current Ratio	5.36	2.81	1.84	1.49	2.26	2.63
Return on Equity (ROE)	5.02%	9.91%	12.37%	11.50%	-0.13%	14.10%
Return on Assets (ROA)	3.41%	5.37%	5.21%	5.45%	0.70%	4.84%
Return on Capital (ROIC)	4.64%	7.11%	7.48%	7.66%	0.88%	6.42%
Earnings Yield	-15.99%	10.15%	10.10%	9.06%	-0.13%	7.97%
FCF Yield	8.58%	22.60%	-12.94%	-1.40%	5.82%	3.46%
Dividend Yield	3.14%	4.14%	3.27%	3.47%	-	-
Payout Ratio	69.70%	35.48%	29.58%	-	-	30.77%
Buyback Yield / Dilution	-0.13%	-	-	-1.28%	-2.64%	-11.47%
Total Shareholder Return	-0.13%	4.14%	3.27%	2.19%	-2.64%	-11.47%

Source: S&P Capital IQ. Standard template. Financial Sources.